Hollsteen
← MercadoLibre

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 2018: $38.0M · 10-Q 0001562762-19-000123 filed May 3, 2019Research and development · Q2 2018: $33.0M · 10-Q 0001562762-19-000186 filed Aug 8, 2019Research and development · Q3 2018: $35.0M · 10-Q 0001562762-19-000273 filed Nov 1, 2019Research and development · Q4 2018: $39.0M · derived · 10-K 0001562762-20-000055 filed Feb 14, 2020Research and development · Q1 2019: $52.0M · 10-Q 0001562762-19-000123 filed May 3, 2019Research and development · Q2 2019: $54.0M · 10-Q 0001562762-19-000186 filed Aug 8, 2019Research and development · Q3 2019: $59.0M · 10-Q 0001562762-19-000273 filed Nov 1, 2019Research and development · Q4 2019: $58.0M · derived · 10-K 0001562762-21-000079 filed Mar 1, 2021Research and development · Q1 2020: $73.0M · 10-Q 0001562762-20-000170 filed May 6, 2020Research and development · Q2 2020: $73.0M · 10-Q 0001562762-20-000324 filed Aug 10, 2020Research and development · Q3 2020: $89.0M · 10-Q 0001562762-20-000390 filed Nov 5, 2020Research and development · Q4 2020: $117M · derived · 10-K 0001562762-22-000049 filed Feb 23, 2022Research and development · Q1 2021: $126M · 10-Q 0001562762-21-000200 filed May 6, 2021Research and development · Q2 2021: $147M · 10-Q 0001562762-21-000313 filed Aug 5, 2021Research and development · Q3 2021: $138M · 10-Q 0001562762-21-000420 filed Nov 5, 2021Research and development · Q4 2021: $179M · derived · 10-K 0001099590-23-000007 filed Feb 24, 2023Research and development · Q1 2022: $234M · 10-Q 0001562762-22-000223 filed May 6, 2022Research and development · Q2 2022: $262M · 10-Q 0001562762-22-000334 filed Aug 4, 2022Research and development · Q3 2022: $278M · 10-Q 0001562762-22-000430 filed Nov 4, 2022Research and development · Q4 2022: $325M · derived · 10-K 0001099590-24-000008 filed Feb 23, 2024Research and development · Q1 2023: $381M · 10-Q 0001099590-23-000013 filed May 4, 2023Research and development · Q2 2023: $368M · 10-Q 0001099590-23-000020 filed Aug 3, 2023Research and development · Q3 2023: $396M · 10-Q 0001099590-23-000033 filed Nov 2, 2023Research and development · Q4 2023: $686M · 10-Q 0001099590-24-000017 filed May 3, 2024Research and development · Q1 2024: $458M · 10-Q 0001099590-24-000017 filed May 3, 2024Research and development · Q2 2024: $460M · 10-Q 0001099590-24-000026 filed Aug 2, 2024Research and development · Q3 2024: $504M · 10-Q 0001099590-24-000042 filed Nov 7, 2024Research and development · Q4 2024: $512M · derived · 10-K 0001099590-26-000006 filed Feb 25, 2026Research and development · Q1 2025: $551M · 10-Q 0001099590-25-000028 filed May 8, 2025Research and development · Q2 2025: $567M · 10-Q 0001099590-25-000044 filed Aug 5, 2025Research and development · Q3 2025: $567M · 10-Q 0001099590-25-000051 filed Oct 30, 2025Research and development · Q4 2025: $584M · derived · 10-K 0001099590-26-000006 filed Feb 25, 2026Research and development · Q1 2026: $699M · 10-Q 0001099590-26-000017 filed May 8, 2026Research and development · Q2 2026: $729M · 10-Q 0001099590-26-000023 filed Aug 6, 2026missing14772938Q1 2016Q2 2026Q2 2021
$MResearch and development · Q2 2020: $73.0M · 10-Q 0001562762-20-000324 filed Aug 10, 2020Research and development · Q3 2020: $89.0M · 10-Q 0001562762-20-000390 filed Nov 5, 2020Research and development · Q4 2020: $117M · derived · 10-K 0001562762-22-000049 filed Feb 23, 2022Research and development · Q1 2021: $126M · 10-Q 0001562762-21-000200 filed May 6, 2021Research and development · Q2 2021: $147M · 10-Q 0001562762-21-000313 filed Aug 5, 2021Research and development · Q3 2021: $138M · 10-Q 0001562762-21-000420 filed Nov 5, 2021Research and development · Q4 2021: $179M · derived · 10-K 0001099590-23-000007 filed Feb 24, 2023Research and development · Q1 2022: $234M · 10-Q 0001562762-22-000223 filed May 6, 202214723473Q2 2020Q1 2022Q2 2021
Q2 2021
147$M
All values (34)
PeriodValue ($M)Status
Q2 2026729reported
Q1 2026699reported
Q4 2025584derived
Q3 2025567reported
Q2 2025567reported
Q1 2025551reported
Q4 2024512derived
Q3 2024504reported
Q2 2024460reported
Q1 2024458reported
Q4 2023686reported
Q3 2023396reported
Q2 2023368reported
Q1 2023381reported
Q4 2022325derived
Q3 2022278reported
Q2 2022262reported
Q1 2022234reported
Q4 2021179derived
Q3 2021138reported
Q2 2021147reported
Q1 2021126reported
Q4 2020117derived
Q3 202089reported
Q2 202073reported
Q1 202073reported
Q4 201958derived
Q3 201959reported
Q2 201954reported
Q1 201952reported
Q4 201839derived
Q3 201835reported
Q2 201833reported
Q1 201838reported
Q1 2016 – Q4 2017–missing (8 periods): No verified SEC value extracted, although the company reports this metric in other periods.

Show reported periods only · CSV with all sources · Technical ID: rnd

More metrics for MercadoLibre

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$147M
Period
Q2 2021, ended Jun 30, 2021 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Aug 5, 2021 · 0001562762-21-000313
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$147MAug 5, 202110-Q 0001562762-21-000313reported · confidence 1. · current